Back to Trials
NCT07483203Recruiting

A Study Of Clinical Implications Of Pulmonary Vascular Disease In Valvular Heart Disease

Mayo Clinic

Start Date

4/28/2026

Completion Date

5/1/2028

Summary

The purpose of this study is to characterize pulmonary hemodynamic profiles, with a focus on PVR subtypes, in patients with left-sided valvular heart disease undergoing aortic or mitral valve intervention, and to identify patterns predicting reversibility of TR and RV dysfunction.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * ≥18 years old; AND * Scheduled for valve procedures Exclusion Criteria: * Congenital heart disease (except for bicuspid aortic valve), OR * Carcinoid heart disease, OR * Valvular mass, OR * Endocarditis, OR * Any other condition that, in the opinion of the investigator, would impair their ability to complete the study

Interventions

DIAGNOSTIC_TEST

Echocardiogram

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Pulmonary Vascular DiseaseValvular Heart Disease

Locations

Mayo Clinic in Rochester

Rochester, Minnesota 55905

United States